What the trial data shows
The SURMOUNT-1 study received the necessary ethical approvals from all study sites, obtained informed patient consent to participate and was conducted in accordance with the Declaration of Helsinki
(This range varies a little bit, depending on who is defining normal)
Results Compared with individuals with NGT, those with type 2 diabetes had higher fasting (7 {\mathrm{O _2 \) and CO 2 production were performed via indirect calorimetry during fasting near steady state when participants were reclined, still and awake between 07:00 h and 07:30 h, using the DELTATRAC II (Sensormedics, USA) at the CNRC or the ParvoMedics TrueOne 2400 Metabolic Measurement System at NIH
While this approval is a significant step, it is crucial to address the ongoing supply issues of GLP-1 medications to ensure uninterrupted access to treatments for individuals with type 2 diabetes
This blog dives into: What food noise actually is Why GLP-1 drugs reduce food noise (but arent a magic solution) The risk of muscle loss during rapid weight loss How age and menopause increase vulnerability Practical strategies to quiet food noise naturally How structure, planning, and mindset shifts can make food feel easier This post is inspired by a recent article in Alan Aragons Research Review (a respected monthly review of studies and expert insights I subscribe to)
